Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-11

Clinical Trial Update: Nimodipine to Prevent LH Surge During Ovulation Induction: Blinded Placebo-controlled RCT [NA]

View source ↗

Summary

Completed blinded placebo-controlled trial evaluating nimodipine to prevent LH surge during ovulation induction in infertility contexts.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nimodipine (Nimodipine)

Snippet

Sponsor: Boston IVF | Conditions: Unexplained Infertility, Polycystic Ovarian Syndrome | NA | Status: COMPLETED | Results posted: 2020-08-11